{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:15:38Z","timestamp":1791818138428,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41401-018-0085-8","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T06:32:39Z","timestamp":1531377159000},"page":"514-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies"],"prefix":"10.1038","volume":"40","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-yan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"issue":"Suppl 1","key":"85_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02919050","volume":"4","author":"G Goldstein","year":"1985","unstructured":"Goldstein G, Audhya TK. Thymopoietin to thymopentin: experimental studies. Surv Immunol Res. 1985;4(Suppl 1):1\u201310.","journal-title":"Surv Immunol Res"},{"key":"85_CR2","first-page":"1045","volume":"44","author":"R Colle","year":"1988","unstructured":"Colle R, Ceschia T, Colatutto A, Biffoni F. Use of thymopentin in autoimmune hemolytic anemia due to chronic lymphocytic leukemia. Curr Ther Res. 1988;44:1045\u20139.","journal-title":"Curr Ther Res"},{"key":"85_CR3","first-page":"1145","volume":"44","author":"E Sundal","year":"1994","unstructured":"Sundal E, Bertelletti D. Thymopentin treatment of rheumatoid arthritis. Arzneim-Forsch. 1994;44:1145\u20139.","journal-title":"Arzneim-Forsch"},{"key":"85_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0192-0561(99)00084-3","volume":"22","author":"B Bodey","year":"2000","unstructured":"Bodey B, Bodey B, Siegel SE, Kaiser HE. Review of thymic hormones in cancer diagnosis and treatment. Int J Immunopharmacol. 2000;22:261\u201373.","journal-title":"Int J Immunopharmacol"},{"key":"85_CR5","first-page":"351","volume":"19","author":"S Coppola","year":"1996","unstructured":"Coppola S, Buccoliero G, Laddago V, Monno L, Perrone A, Guida G, et al. Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: a pilot study. New Microbiol. 1996;19:351\u20135.","journal-title":"New Microbiol"},{"key":"85_CR6","first-page":"24","volume":"17","author":"C Xiaojing","year":"2017","unstructured":"Xiaojing C, Yanfang L, Yanqing G, Fangfang C. Thymopentin improves cardiac function in older patients with chronic heart failure. Anatol J Cardiol. 2017;17:24\u201330.","journal-title":"Anatol J Cardiol"},{"key":"85_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF02786456","volume":"17","author":"VK Singh","year":"1998","unstructured":"Singh VK, Biswas S, Mathur KB, Haq W, Garg SK, Agarwal SS. Thymopentin and splenopentin as immunomodulators. Curr Status Immunol Res. 1998;17:345\u201368.","journal-title":"Curr Status Immunol Res"},{"key":"85_CR8","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1080\/07391102.2013.834851","volume":"32","author":"MS Kondratyev","year":"2014","unstructured":"Kondratyev MS, Lunin SM, Kabanov AV, Samchenko AA, Komarov VM, Fesenko EE, et al. Structural and dynamic properties of thymopoietin mimetics. J Biomol Struct Dyn. 2014;32:1793\u2013801.","journal-title":"J Biomol Struct Dyn"},{"key":"85_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0031-6865(99)00005-9","volume":"73","author":"S Gonser","year":"1999","unstructured":"Gonser S, Weber E, Folkers G. Peptides and polypeptides as modulators of the immune response: thymopentin--an example with unknown mode of action. Pharm Acta Helv. 1999;73:265\u201373.","journal-title":"Pharm Acta Helv"},{"issue":"Suppl 1","key":"85_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02919052","volume":"4","author":"TK Audhya","year":"1985","unstructured":"Audhya TK, Goldstein G. Thymopentin: stability considerations and potency by various routes of administration. Surv Immunol Res. 1985;4(Suppl 1):17\u201323.","journal-title":"Surv Immunol Res"},{"key":"85_CR11","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s11095-010-0201-z","volume":"27","author":"YZ Li","year":"2010","unstructured":"Li YZ, Sun X, Gong T, Liu J, Zuo J, Zhang ZR. Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles. Pharm Res. 2010;27:1977\u201386.","journal-title":"Pharm Res"},{"key":"85_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1399-3011.1983.tb02130.x","volume":"22","author":"T Audhya","year":"1983","unstructured":"Audhya T, Goldstein G. Thymopentin (TP-5) potency in vivo is enhanced by slow infusion. Int J Pept Protein Res. 1983;22:568\u201372.","journal-title":"Int J Pept Protein Res"},{"key":"85_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2006.09.015","volume":"116","author":"Y Yin","year":"2006","unstructured":"Yin Y, Chen D, Qiao M, Lu Z, Hu H. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. J Control Release. 2006;116:337\u201345.","journal-title":"J Control Release"},{"key":"85_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2007.06.024","volume":"123","author":"Y Yin","year":"2007","unstructured":"Yin Y, Chen D, Qiao M, Wei X, Hu H. Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution. J Control Release. 2007;123:27\u201338.","journal-title":"J Control Release"},{"key":"85_CR15","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1021\/mp400722r","volume":"11","author":"C Wu","year":"2014","unstructured":"Wu C, Zhang M, Zhang Z, Wan KW, Ahmed W, Phoenix DA, et al. Thymopentin nanoparticles engineered with high loading efficiency, improved pharmacokinetic properties, and enhanced immunostimulating effect using soybean phospholipid and PHBHHx polymer. Mol Pharm. 2014;11:3371\u20137.","journal-title":"Mol Pharm"},{"key":"85_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijpharm.2010.07.036","volume":"398","author":"G Wei","year":"2010","unstructured":"Wei G, Jin L, Xu L, Liu Y, Lu W. Preparation, characterization and in vivo pharmacodynamic evaluation of thymopentin loaded poly(lactide acid)\/poly(lactide-co-glycolide acid) implants. Int J Pharm. 2010;398:123\u20139.","journal-title":"Int J Pharm"},{"key":"85_CR17","first-page":"15","volume":"386","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Wu X, Han Y, Mo F, Duan Y, Li S. Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels. nt J Pharm. 2010;386:15\u201322.","journal-title":"nt J Pharm"},{"key":"85_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejpb.2017.10.011","volume":"122","author":"S Lin","year":"2018","unstructured":"Lin S, Cai B, Quan G, Peng T, Yao G, Zhu C, et al. Novel strategy for immunomodulation: dissolving microneedle array encapsulating thymopentin fabricated by modified two-step molding technology. Eur J Pharm Biopharm. 2018;122:104\u201312.","journal-title":"Eur J Pharm Biopharm"},{"key":"85_CR19","first-page":"811","volume":"68","author":"Y Zhong","year":"2013","unstructured":"Zhong Y, Chen L, Zhang Y, Li W, Sun X, Gong T, et al. Vesicular phospholipid gels using low concentrations of phospholipids for the sustained release of thymopentin: pharmacokinetics and pharmacodynamics. Pharmazie. 2013;68:811\u20135.","journal-title":"Pharmazie"},{"key":"85_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2014.12.042","volume":"45","author":"T Zhang","year":"2015","unstructured":"Zhang T, Peng Q, San FY, Luo JW, Wang MX, Wu WQ, et al. A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides. Biomaterials. 2015;45:1\u20139.","journal-title":"Biomaterials"},{"key":"85_CR21","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1021\/ja0037926","volume":"123","author":"BA Simmons","year":"2001","unstructured":"Simmons BA, Taylor CE, Landis FA, John VT, McPherson GL, Schwartz DK, et al. Microstructure determination of AOT+ phenol organogels utilizing small-angle X-ray scattering and atomic force microscopy. J Am Chem Soc. 2001;123:2414\u201321.","journal-title":"J Am Chem Soc"},{"key":"85_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2014.04.034","volume":"185","author":"MH Ki","year":"2014","unstructured":"Ki MH, Lim JL, Ko JY, Park SH, Kim JE, Cho HJ, et al. A new injectable liquid crystal system for one month delivery of leuprolide. J Control Release. 2014;185:62\u201370.","journal-title":"J Control Release"},{"key":"85_CR23","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1089\/10430349950016834","volume":"10","author":"A Sauerbrey","year":"1999","unstructured":"Sauerbrey A, McPherson JP, Zhao SC, Banerjee D, Bertino JR. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside. Hum Gene Ther. 1999;10:2495\u2013504.","journal-title":"Hum Gene Ther"},{"key":"85_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","volume":"229","author":"F Ravar","year":"2016","unstructured":"Ravar F, Saadat E, Gholami M, Dehghankelishadi P, Mahdavi M, Azami S, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10\u201322.","journal-title":"J Control Release"},{"key":"85_CR25","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.biomaterials.2011.10.072","volume":"33","author":"Q Peng","year":"2012","unstructured":"Peng Q, Zhang ZR, Gong T, Chen GQ, Sun X. A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles. Biomaterials. 2012;33:1583\u20138.","journal-title":"Biomaterials"},{"key":"85_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2016.03.036","volume":"230","author":"M Wang","year":"2016","unstructured":"Wang M, Shan F, Zou Y, Sun X, Zhang ZR, Fu Y, et al. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide. J J Control Release. 2016;230:45\u201356.","journal-title":"J J Control Release"},{"key":"85_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.colsurfa.2011.10.010","volume":"392","author":"J Gurfinkel","year":"2011","unstructured":"Gurfinkel J, Aserin A, Garti N. Interactions of surfactants in nonionic\/anionic reverse hexagonal mesophases and solubilization of \u03b1-chymotrypsinogen A. Colloids Surf A. 2011;392:322\u20138.","journal-title":"Colloids Surf A"},{"key":"85_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1399-3011.1979.tb01959.x","volume":"14","author":"JP Tischio","year":"1979","unstructured":"Tischio JP, Patrick JE, Weintraub HS, Chasin M, Goldstein G. Short in vitro half-life of thymopoietin32--36 pentapeptide in human plasma. Int J Pept Protein Res. 1979;14:479\u201384.","journal-title":"Int J Pept Protein Res"},{"key":"85_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.yexcr.2014.12.012","volume":"331","author":"MX Zhu","year":"2015","unstructured":"Zhu MX, Wan WL, Li HS, Wang J, Chen GA, Ke XY. Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells in vitro. Exp Cell Res. 2015;331:387\u201398.","journal-title":"Exp Cell Res"},{"key":"85_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.peptides.2005.09.008","volume":"27","author":"J Wang","year":"2006","unstructured":"Wang J, Lu WL, Liang GW, Wu KC, Zhang CG, Zhang X, et al. Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers. Peptides. 2006;27:826\u201335.","journal-title":"Peptides"},{"key":"85_CR31","first-page":"827","volume":"116","author":"X Tang","year":"2003","unstructured":"Tang X, Yin C, Zhang F, Fu Y, Chen W, Chen Y, et al. Measurement of subgroups of peripheral blood T lymphocytes in patients with severe acute respiratory syndrome and its clinical significance. Chin Med J. 2003;116:827\u201330.","journal-title":"Chin Med J"},{"key":"85_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1365-2362.2000.00642.x","volume":"30","author":"A Treitinger","year":"2000","unstructured":"Treitinger A, Spada C, Verdi JC, Miranda AF, Oliveira OV, Silveira MV, et al. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur J Clin Invest. 2000;30:454\u20139.","journal-title":"Eur J Clin Invest"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0085-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0085-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0085-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:21Z","timestamp":1684616481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0085-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0085-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}